Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability
- PMID: 7617175
- DOI: 10.1212/wnl.45.7.1245
Copolymer 1: a most reasonable alternative therapy for early relapsing-remitting multiple sclerosis with mild disability
Comment in
-
Editorials in scientific publications.Neurology. 1996 Mar;46(3):883. Neurology. 1996. PMID: 8618717 No abstract available.
Comment on
-
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.Neurology. 1995 Jul;45(7):1268-76. doi: 10.1212/wnl.45.7.1268. Neurology. 1995. PMID: 7617181 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical